JP2021514001A5 - - Google Patents
Info
- Publication number
- JP2021514001A5 JP2021514001A5 JP2020544510A JP2020544510A JP2021514001A5 JP 2021514001 A5 JP2021514001 A5 JP 2021514001A5 JP 2020544510 A JP2020544510 A JP 2020544510A JP 2020544510 A JP2020544510 A JP 2020544510A JP 2021514001 A5 JP2021514001 A5 JP 2021514001A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- alkylene
- salt according
- salt
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024009496A JP2024056735A (ja) | 2018-02-23 | 2024-01-25 | Ｅｇｆｒ二量体撹乱剤およびその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862634452P | 2018-02-23 | 2018-02-23 | |
| US62/634,452 | 2018-02-23 | ||
| PCT/US2019/019391 WO2019165358A1 (en) | 2018-02-23 | 2019-02-25 | Egfr dimer disruptors and use of the same |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024009496A Division JP2024056735A (ja) | 2018-02-23 | 2024-01-25 | Ｅｇｆｒ二量体撹乱剤およびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021514001A JP2021514001A (ja) | 2021-06-03 |
| JP2021514001A5 true JP2021514001A5 (https=) | 2022-03-03 |
| JP7497046B2 JP7497046B2 (ja) | 2024-06-10 |
Family
ID=67688515
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020544510A Active JP7497046B2 (ja) | 2018-02-23 | 2019-02-25 | Ｅｇｆｒ二量体撹乱剤およびその使用 |
| JP2024009496A Pending JP2024056735A (ja) | 2018-02-23 | 2024-01-25 | Ｅｇｆｒ二量体撹乱剤およびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024009496A Pending JP2024056735A (ja) | 2018-02-23 | 2024-01-25 | Ｅｇｆｒ二量体撹乱剤およびその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11358965B2 (https=) |
| EP (1) | EP3755323A4 (https=) |
| JP (2) | JP7497046B2 (https=) |
| KR (1) | KR102748047B1 (https=) |
| CN (1) | CN111886009A (https=) |
| AU (1) | AU2019223168B2 (https=) |
| BR (1) | BR112020017184A2 (https=) |
| CA (1) | CA3091834A1 (https=) |
| EA (1) | EA202092000A1 (https=) |
| MX (1) | MX2020008767A (https=) |
| WO (1) | WO2019165358A1 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3755323A4 (en) | 2018-02-23 | 2021-11-24 | The Regents Of The University Of Michigan | EGFR DIMER DISRUPTORS AND THEIR USES |
| MX2022002108A (es) * | 2019-08-22 | 2022-03-17 | Univ Michigan Regents | Metodo para tratar canceres asociados con kras. |
| WO2021178741A1 (en) * | 2020-03-05 | 2021-09-10 | The Regents Of The University Of Michigan | Inhibitors of egfr, kras, braf, and other targets and use of the same |
| CN115397413A (zh) * | 2020-03-05 | 2022-11-25 | 密歇根大学董事会 | Egfr、kras、braf和其他靶标的抑制剂及其用途 |
| KR20230094197A (ko) | 2020-09-23 | 2023-06-27 | 스코르피온 테라퓨틱스, 인코퍼레이티드 | 암 치료에 유용한 피롤로[3,2-c]피리딘-4-온 유도체들 |
| WO2022072632A1 (en) | 2020-09-30 | 2022-04-07 | Scorpion Therapeutics, Inc. | Bicyclic compounds for use in the treatment cancer |
| WO2022072645A2 (en) | 2020-09-30 | 2022-04-07 | Scorpion Therapeutics, Inc. | Methods for treating cancer |
| TW202229282A (zh) | 2020-09-30 | 2022-08-01 | 美商史考皮恩治療有限公司 | 治療癌症之方法 |
| KR20230107419A (ko) | 2020-10-09 | 2023-07-14 | 스코르피온 테라퓨틱스, 인코퍼레이티드 | 암 치료 방법 |
| WO2022077154A1 (en) * | 2020-10-12 | 2022-04-21 | The Regents Of The University Of Michigan | Synthesis of egfr modulators |
| US20240018144A1 (en) * | 2020-10-12 | 2024-01-18 | The Regents Of The University Of Michigan | Synthesis of EGFR Modulators |
| WO2022094271A1 (en) | 2020-10-30 | 2022-05-05 | Scorpion Therapeutics, Inc. | Methods for treating cancer |
| WO2022098992A1 (en) | 2020-11-05 | 2022-05-12 | Scorpion Therapeutics, Inc. | Use of macrocyclic compounds in methods of treating cancer |
| WO2022197913A1 (en) | 2021-03-18 | 2022-09-22 | Scorpion Therapeutics, Inc. | Bicyclic derivatives which can be used to treat cancer |
| TW202309022A (zh) | 2021-04-13 | 2023-03-01 | 美商努法倫特公司 | 用於治療具egfr突變之癌症之胺基取代雜環 |
| WO2023173083A1 (en) | 2022-03-11 | 2023-09-14 | Scorpion Therapeutics, Inc. | Tetrahydroindole derivatives as egfr and/or her2 inhibtors useful for the treatment of cancer |
| WO2024254298A1 (en) | 2023-06-08 | 2024-12-12 | Scorpion Therapeutics, Inc. | A 1,5-dihydro-4h-pyrrolo[3,2-c] pyridin-4-one for use in the treatment of cancer |
| CN121712773A (zh) | 2023-06-08 | 2026-03-20 | 安塔列斯疗法股份有限公司 | 1,5-二氢-4h-吡咯并[3,2-c]吡啶-4-酮用于癌症治疗 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3547977A (en) | 1967-10-27 | 1970-12-15 | Velsicol Chemical Corp | Novel carbanilates |
| US5466468A (en) | 1990-04-03 | 1995-11-14 | Ciba-Geigy Corporation | Parenterally administrable liposome formulation comprising synthetic lipids |
| WO2009086303A2 (en) | 2007-12-21 | 2009-07-09 | University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
| WO2012087943A2 (en) | 2010-12-20 | 2012-06-28 | The Regents Of The University Of Michigan | Inhibitors of the epidermal growth factor receptor-heat shock protein 90 binding interaction |
| WO2014176475A2 (en) * | 2013-04-26 | 2014-10-30 | The Regents Of The University Of Michigan | Egfr inhibitors and uses thereof |
| EP3096761A1 (en) * | 2014-01-24 | 2016-11-30 | Confluence Life Sciences, Inc. | Substituted pyroolopyridines and pyrrolopyrazines for treating cancer or inflammatory diseases |
| WO2016105525A2 (en) * | 2014-12-23 | 2016-06-30 | Dana-Farber Cancer Institute, Inc. | Novel pyrimidines as egfr inhibitors and methods of treating disorders |
| EP3755323A4 (en) | 2018-02-23 | 2021-11-24 | The Regents Of The University Of Michigan | EGFR DIMER DISRUPTORS AND THEIR USES |
-
2019
- 2019-02-25 EP EP19757355.3A patent/EP3755323A4/en active Pending
- 2019-02-25 KR KR1020207027147A patent/KR102748047B1/ko active Active
- 2019-02-25 MX MX2020008767A patent/MX2020008767A/es unknown
- 2019-02-25 CN CN201980020234.3A patent/CN111886009A/zh active Pending
- 2019-02-25 CA CA3091834A patent/CA3091834A1/en active Pending
- 2019-02-25 EA EA202092000A patent/EA202092000A1/ru unknown
- 2019-02-25 AU AU2019223168A patent/AU2019223168B2/en active Active
- 2019-02-25 US US16/970,655 patent/US11358965B2/en active Active
- 2019-02-25 WO PCT/US2019/019391 patent/WO2019165358A1/en not_active Ceased
- 2019-02-25 BR BR112020017184-0A patent/BR112020017184A2/pt unknown
- 2019-02-25 JP JP2020544510A patent/JP7497046B2/ja active Active
-
2022
- 2022-05-09 US US17/739,358 patent/US11999731B2/en active Active
-
2024
- 2024-01-25 JP JP2024009496A patent/JP2024056735A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021514001A5 (https=) | ||
| JP2021523200A5 (https=) | ||
| JP2024050527A5 (https=) | ||
| JP2022551185A5 (https=) | ||
| JP2021513534A5 (https=) | ||
| JP2007502295A5 (https=) | ||
| JP2024512154A5 (https=) | ||
| JP2022510313A5 (https=) | ||
| JP2019518766A5 (https=) | ||
| JP2011509309A5 (https=) | ||
| JP2020532547A5 (https=) | ||
| JP2015516420A5 (https=) | ||
| RU2005107314A (ru) | Пиримидопроизводные, характеризующиеся антипролиферативной активностью | |
| JP2020529994A5 (https=) | ||
| JP2023533203A5 (https=) | ||
| JP2012526728A5 (https=) | ||
| JP2021105002A5 (https=) | ||
| RU2004104625A (ru) | Аналоги простагландинов в качестве агонистов рецептора ep4 | |
| JP2011520815A5 (https=) | ||
| JP2015514063A5 (https=) | ||
| JP2020502047A5 (https=) | ||
| JP2013544276A5 (https=) | ||
| JP2024516033A5 (https=) | ||
| JP2023531709A5 (https=) | ||
| JP2023504542A5 (https=) |